Insufficient scRNA-seq data for expression of SLC10A6 at single-cell level.
Insufficient scRNA-seq data for expression of SLC10A6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 93% | 207.17 | 429 / 459 | 47% | 1.30 | 528 / 1118 |
esophagus | 54% | 157.71 | 781 / 1445 | 71% | 7.65 | 130 / 183 |
thymus | 60% | 58.22 | 395 / 653 | 42% | 0.89 | 254 / 605 |
adipose | 99% | 280.90 | 1186 / 1204 | 0% | 0 | 0 / 0 |
skin | 72% | 643.15 | 1306 / 1809 | 18% | 0.58 | 86 / 472 |
tonsil | 0% | 0 | 0 / 0 | 78% | 7.01 | 35 / 45 |
uterus | 21% | 21.65 | 36 / 170 | 49% | 7.43 | 226 / 459 |
bladder | 24% | 25.29 | 5 / 21 | 28% | 1.65 | 142 / 504 |
kidney | 0% | 0 | 0 / 89 | 47% | 1.74 | 420 / 901 |
lung | 14% | 11.57 | 80 / 578 | 33% | 1.89 | 378 / 1155 |
prostate | 18% | 15.75 | 43 / 245 | 24% | 0.42 | 119 / 502 |
stomach | 10% | 7.49 | 35 / 359 | 25% | 0.45 | 72 / 286 |
intestine | 17% | 13.50 | 163 / 966 | 18% | 0.51 | 95 / 527 |
pancreas | 1% | 0.66 | 4 / 328 | 29% | 1.02 | 51 / 178 |
blood vessel | 25% | 27.95 | 337 / 1335 | 0% | 0 | 0 / 0 |
muscle | 21% | 16.75 | 165 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 2% | 1.54 | 4 / 258 | 19% | 0.56 | 43 / 230 |
brain | 0% | 0.34 | 12 / 2642 | 17% | 0.61 | 120 / 705 |
heart | 15% | 15.58 | 133 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 4% | 0.08 | 18 / 406 |
spleen | 3% | 2.07 | 8 / 241 | 0% | 0 | 0 / 0 |
ovary | 2% | 2.59 | 3 / 180 | 1% | 0.01 | 3 / 430 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015721 | Biological process | bile acid and bile salt transport |
GO_0006814 | Biological process | sodium ion transport |
GO_0055085 | Biological process | transmembrane transport |
GO_0043251 | Biological process | sodium-dependent organic anion transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0008508 | Molecular function | bile acid:sodium symporter activity |
GO_0043250 | Molecular function | sodium-dependent organic anion transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC10A6 |
Protein name | Sodium-dependent organic anion transporter (SOAT) (Solute carrier family 10 member 6) (SLC10A6) |
Synonyms | SOAT |
Description | FUNCTION: Transports sulfoconjugated steroid hormones from the extracellular compartment into the cytosol in a sodium-dependent manner without hydrolysis . Steroid sulfate hormones are commonly considered to be biologically inactive metabolites, that may be activated by steroid sulfatases into free steroids . May play an important role by delivering sulfoconjugated steroids to specific target cells in reproductive organs (By similarity). May play a role transporting the estriol precursor 16alpha-hydroxydehydroepiandrosterone 3-sulfate (16a-OH-DHEAS) at the fetal blood vessel endothelium . Can also transport other sulfoconjugated molecules such as taurolithocholic acid-3-sulfate and sulfoconjugated pyrenes . . |
Accessions | ENST00000273905.7 Q3KNW5 |